{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:15:27Z","timestamp":1790342127371,"version":"4.1.0"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.brainres.2019.146359","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T13:22:45Z","timestamp":1564492965000},"page":"146359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder"],"prefix":"10.1016","volume":"1731","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2822-3754","authenticated-orcid":false,"given":"Robert","family":"Suchting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin H.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe G. San","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel R.","family":"Fries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy M.","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2019.146359_b0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/00952990.2011.644002","article-title":"The efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression","volume":"38","author":"Afshar","year":"2012","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.brainres.2019.146359_b0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1037\/1040-3590.10.2.176","article-title":"Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales (DASS) in clinical groups and a community sample","volume":"10","author":"Antony","year":"1998","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.brainres.2019.146359_b0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.psyneuen.2013.10.010","article-title":"Anxiolytic function of the orexin 2\/hypocretin A receptor in the basolateral amygdala","volume":"40","author":"Arendt","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"Suppl 1","key":"10.1016\/j.brainres.2019.146359_b0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuropharm.2008.06.060","article-title":"Role of lateral hypothalamic orexin neurons in reward processing and addiction","volume":"56","author":"Aston-Jones","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.146359_b0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.drugalcdep.2009.07.016","article-title":"Reactivity to laboratory stress provocation predicts relapse to cocaine","volume":"106","author":"Back","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainres.2019.146359_b0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/B978-0-12-394623-2.00016-0","article-title":"Cocaine and nicotine research illustrates a range of hypocretin mechanisms in addiction","volume":"89","author":"Baimel","year":"2012","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.brainres.2019.146359_b0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/hup.1019","article-title":"How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database","volume":"24","author":"Baldwin","year":"2009","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.brainres.2019.146359_b0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.31887\/DCNS.2017.19.2\/bbandelow","article-title":"Treatment of anxiety disorders","volume":"19","author":"Bandelow","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.brainres.2019.146359_b0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/bs.irn.2017.06.006","article-title":"Orexin\/hypocretin system: role in food and drug overconsumption","volume":"136","author":"Barson","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.brainres.2019.146359_b0050","first-page":"264","article-title":"Suvorexant, a dual orexin receptor antagonist for the management of insomnia","volume":"39","author":"Bennett","year":"2014","journal-title":"Pharm. Therpeutics"},{"key":"10.1016\/j.brainres.2019.146359_b0055","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/ejn.12866","article-title":"Orexin-1 receptor signaling increases motivation for cocaine-associated cues","volume":"41","author":"Bentzley","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146359_b0060","article-title":"Hypocretin receptor 1 knockdown in the ventral tegmental area attenuates mesolimbic dopamine signaling and reduces motivation for cocaine","author":"Bernstein","year":"2017","journal-title":"Addict. Biol."},{"key":"10.1016\/j.brainres.2019.146359_b0065","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.mehy.2013.12.026","article-title":"Relationships between sleep and addiction: the role of drug-environment conditioning","volume":"82","author":"Berro","year":"2014","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.brainres.2019.146359_b0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2007.11.023","article-title":"Drug use and dependence in cocaine dependent subjects, community-based individuals, and their siblings","volume":"95","author":"Bierut","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainres.2019.146359_b0075","article-title":"Hypocretin receptor 1 involvement in cocaine-associated behavior: therapeutic potential and novel mechanistic insights","author":"Brodnik","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.146359_b0080","first-page":"135","article-title":"Are you sleeping? Pilot comparison of self-reported and objective measures of sleep quality and duration in an inpatient alcoholism treatment program","volume":"6","author":"Brooks","year":"2012","journal-title":"Subst. Abus."},{"key":"10.1016\/j.brainres.2019.146359_b0085","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/j.1530-0277.1998.tb03995.x","article-title":"Polysomnographic and subjective sleep predictors of alcoholic relapse","volume":"22","author":"Brower","year":"1998","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.brainres.2019.146359_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v080.i01","article-title":"brms: an R package for Bayesian multilevel models using Stan","volume":"80","author":"B\u00fcrkner","year":"2017","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.brainres.2019.146359_b0095","doi-asserted-by":"crossref","DOI":"10.3109\/00952990.2011.643986","article-title":"Measures of attentional bias and relational responding are associated with behavioral treatment outcome for cocaine dependence","author":"Carpenter","year":"2012","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.brainres.2019.146359_b0100","doi-asserted-by":"crossref","first-page":"13300","DOI":"10.1523\/JNEUROSCI.1065-15.2015","article-title":"Sleep regulates incubation of cocaine craving","volume":"35","author":"Chen","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146359_b0105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fphys.2017.00357","article-title":"Orexin system: the key for a healthy life","volume":"8","author":"Chieffi","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.brainres.2019.146359_b0110","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00213-017-4580-2","article-title":"Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment","volume":"234","author":"Cinciripini","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainres.2019.146359_b0115","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pharmtox-010716-104837","article-title":"The discovery of suvorexant, the first orexin receptor drug for insomnia","volume":"57","author":"Coleman","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.brainres.2019.146359_b0120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1037\/a0029599","article-title":"Cue reactivity as a predictor of successful abstinence initiation among adult smokers","volume":"20","author":"Conklin","year":"2012","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.brainres.2019.146359_b0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0376-8716(02)00219-3","article-title":"Alcohol attentional bias as a predictor of alcohol abusers\u2019 treatment outcome","volume":"68","author":"Cox","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainres.2019.146359_b0130","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/pr.115.011668","article-title":"Evaluation of the \u201cpipeline\u201d for development of medications for cocaine use disorder: a review of translational preclinical, human laboratory, and clinical trial research","volume":"68","author":"Czoty","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.brainres.2019.146359_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002715","article-title":"Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: a systematic review and network meta-analysis","volume":"15","author":"De Crescenzo","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.brainres.2019.146359_b0140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/npp.2012.179","article-title":"An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans","volume":"38","author":"Dean","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2019.146359_b0145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/ADT.0000000000000046","article-title":"Demographic and psychological factors associated with lifetime cocaine use: an exploratory factor analysis of baseline questionnaires","volume":"14","author":"Dias","year":"2015","journal-title":"Addict. Disord. Their Treat."},{"key":"10.1016\/j.brainres.2019.146359_b0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbr.2015.07.006","article-title":"Anti-saccade error rates as a measure of attentional bias in cocaine dependent subjects","volume":"292","author":"Dias","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2019.146359_b0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.addbeh.2015.03.025","article-title":"Cue-induced craving in patients with cocaine use disorder predicts cognitive control deficits toward cocaine cues","volume":"47","author":"DiGirolamo","year":"2015","journal-title":"Addict. Behav."},{"key":"10.1016\/j.brainres.2019.146359_b0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1037\/a0027789","article-title":"Effects of divalproex on smoking cue reactivity and cessation outcomes among smokers achieving initial abstinence","volume":"20","author":"Ditre","year":"2012","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.brainres.2019.146359_b0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-psych-122414-033457","article-title":"Drug addiction: updating actions to habits to compulsions ten years on","volume":"67","author":"Everitt","year":"2016","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.brainres.2019.146359_b0170","first-page":"5737","article-title":"Drug addiction: updating actions to habits to compulsions ten years on","author":"Everitt","year":"2016","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.brainres.2019.146359_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2008.03.030","article-title":"Attentional bias in addictive behaviors: a review of its development, causes, and consequences","volume":"97","author":"Field","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainres.2019.146359_b0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.drugalcdep.2006.03.018","article-title":"Selective processing of cannabis cues in regular cannabis users","volume":"85","author":"Field","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainres.2019.146359_b0185","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1017\/S1092852913000321","article-title":"The clinical relevance of attentional bias in substance use disorders","volume":"19","author":"Field","year":"2014","journal-title":"CNS Spectr."},{"key":"10.1016\/j.brainres.2019.146359_b0190","series-title":"Structured Clinical Interview for DSM-5\u2014Research Version (SCID-5 for DSM-5, Research Version; SCID-5-RV)","author":"First","year":"2015"},{"key":"10.1016\/j.brainres.2019.146359_b0195","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.drugalcdep.2018.04.018","article-title":"Hypocretin\/orexin antagonists decrease cocaine self-administration by female rhesus monkeys","volume":"188","author":"Foltin","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainres.2019.146359_b0200","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamapsychiatry.2016.2157","article-title":"Association of the sweet-liking phenotype and craving for alcohol with the response to naltrexone treatment in alcohol dependence: a randomized clinical trial","volume":"73","author":"Garbutt","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.brainres.2019.146359_b0205","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/ajad.12291","article-title":"Polysomnographic sleep disturbances in nicotine, caffeine, alcohol, cocaine, opioid, and cannabis use: a focused review","volume":"24","author":"Garcia","year":"2015","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.brainres.2019.146359_b0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-011-2618-4","article-title":"Cue-elicited heart rate variability and attentional bias predict alcohol relapse following treatment","volume":"222","author":"Garland","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2019.146359_b0215","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.appet.2012.08.025","article-title":"Plasma cortisol levels in response to a cold pressor test did not predict appetite or ad libitum test meal intake in obese women","volume":"59","author":"Geliebter","year":"2012","journal-title":"Appetite"},{"key":"10.1016\/j.brainres.2019.146359_b0220","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1214\/06-BA117A","article-title":"Prior distribution for variance parameters in hierarchical models","volume":"1","author":"Gelman","year":"2006","journal-title":"Bayesian Anal."},{"key":"10.1016\/j.brainres.2019.146359_b0225","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/npp.2017.158","article-title":"Effects of suvorexant, a dual orexin\/hypocretin receptor antagonist, on impulsive behavior associated with cocaine","volume":"43","author":"Gentile","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2019.146359_b0230","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/adb.12507","article-title":"Suvorexant, an orexin\/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine","volume":"23","author":"Gentile","year":"2018","journal-title":"Addict. Biol."},{"key":"10.1016\/j.brainres.2019.146359_b0235","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.physbeh.2011.11.004","article-title":"Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems","volume":"106","author":"George","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.brainres.2019.146359_b0240","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.euroneuro.2003.08.004","article-title":"The impact of stress on addiction","volume":"13","author":"Goeders","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2019.146359_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.07.003","article-title":"Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients","volume":"87","author":"Gonzalez","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainres.2019.146359_b0250","series-title":"Neurobiology of Addictions","first-page":"301","article-title":"Increasing the information yield from clinical trials in addictions: Bayesian statistics, adaptive designs, and biomarker evaluation","author":"Green","year":"2016"},{"key":"10.1016\/j.brainres.2019.146359_b0255","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5812\/ijhrba.10695","article-title":"Effectiveness of stress management skill training on the depression, anxiety and stress levels in drug addicts after drug withdrawal","volume":"2","author":"Habibi","year":"2013","journal-title":"Int. J. High Risk Behav. Addict."},{"key":"10.1016\/j.brainres.2019.146359_b0260","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/00952990.2017.1355919","article-title":"Neuropsychological comparisons of cocaine versus methamphetamine users: a research synthesis and meta-analysis","volume":"44","author":"Hall","year":"2018","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.brainres.2019.146359_b0265","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature04071","article-title":"A role for lateral hypothalamic orexin neurons in reward seeking","volume":"437","author":"Harris","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2019.146359_b0270","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/FBP.0b013e328014139d","article-title":"Gabapentin does not reduce smoked cocaine self-administration: employment of a novel self-administration procedure","volume":"18","author":"Hart","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146359_b0275","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jsat.2006.05.009","article-title":"Heroin and cocaine craving and use during treatment: measurement validation and potential relationships","volume":"31","author":"Heinz","year":"2006","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.brainres.2019.146359_b0280","series-title":"Eye Tracking: A Comprehensove Guide to Methods and Measures","author":"Holmqvist","year":"2011"},{"key":"10.1016\/j.brainres.2019.146359_b0285","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/wps.20227","article-title":"The NIMH experimental medicine initiative","volume":"14","author":"Insel","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.brainres.2019.146359_b0290","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/7854_2016_57","article-title":"A decade of orexin\/hypocretin and addiction: where are we now?","volume":"33","author":"James","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.brainres.2019.146359_b0295","article-title":"Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin\/hypocretin-1 receptor antagonist in rats","author":"James","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146359_b0300","article-title":"Increased number and activity of a lateral subpopulation of hypothalamic orexin\/hypocretin neurons underlies the expression of an addicted state in rats","author":"James","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2019.146359_b0305","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00213-011-2230-7","article-title":"Clonidine blocks stress-induced craving in cocaine users","volume":"218","author":"Jobes","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2019.146359_b0310","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nm.2075","article-title":"A key role for orexin in panic anxiety","volume":"16","author":"Johnson","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2019.146359_b0315","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/B978-0-444-59489-1.00009-4","article-title":"Orexin, stress, and anxiety\/panic states","volume":"198","author":"Johnson","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.brainres.2019.146359_b0320","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.npp.1301564","article-title":"Drug addiction as a pathology of staged neuroplasticity","volume":"33","author":"Kalivas","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2019.146359_b0325","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.sleep.2017.06.012","article-title":"Actigraphy scoring for sleep outcome measures in chronic obstructive pulmonary disease","volume":"37","author":"Kapella","year":"2017","journal-title":"Sleep Med."},{"key":"10.1016\/j.brainres.2019.146359_b0330","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0376-8716(02)00308-3","article-title":"The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications","volume":"69","author":"Kellogg","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainres.2019.146359_b0335","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000365283","article-title":"Screening of current post-traumatic stress disorder in patients with substance use disorder using the Depression, Anxiety and Stress Scale (DASS-21): a reliable and convenient measure","volume":"21","author":"Kok","year":"2015","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.brainres.2019.146359_b0340","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.2007.05030503","article-title":"Stress, dysregulation of drug reward pathways, and the transition to drug dependence","volume":"164","author":"Koob","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2019.146359_b0345","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.brainres.2019.146359_b0350","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/sj.npp.1300851","article-title":"Cue-induced brain activity changes and relapse in cocaine-dependent patients","volume":"31","author":"Kosten","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2019.146359_b0355","series-title":"How Many Subjects? Statistical Power Analysis in Research","author":"Kraemer","year":"2016"},{"key":"10.1016\/j.brainres.2019.146359_b0360","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2165\/00023210-200115050-00006","article-title":"Sleep abnormalities during abstinence in alcohol-dependent patients","volume":"15","author":"Landolt","year":"2001","journal-title":"Aetiol. Manage. CNS Drugs"},{"key":"10.1016\/j.brainres.2019.146359_b0365","doi-asserted-by":"crossref","first-page":"305","DOI":"10.31887\/DCNS.2005.7.4\/olebon","article-title":"Contribution of sleep research to the development of new antidepressants","volume":"7","author":"Le Bon","year":"2005","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.brainres.2019.146359_b0370","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/a0037806","article-title":"A critical review of the literature on attentional bias in cocaine use disorder and suggestions for future research","volume":"22","author":"Leeman","year":"2014","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.brainres.2019.146359_b0375","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-8986.1975.tb01289.x","article-title":"The cold pressor test and autonomic function: a review and integration","volume":"12","author":"Lovallo","year":"1975","journal-title":"Psychophysiology"},{"key":"10.1016\/j.brainres.2019.146359_b0380","article-title":"Orexin-mediated restoration of hippocampal synaptic potentiation in mice with established cocaine-conditioned place preference","author":"Lu","year":"2018","journal-title":"Addict. Biol."},{"key":"10.1016\/j.brainres.2019.146359_b0385","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S1092852913000485","article-title":"Pharmacological interventions to modulate attentional bias in addiction","volume":"19","author":"Luijten","year":"2014","journal-title":"CNS Spectr."},{"key":"10.1016\/j.brainres.2019.146359_b0390","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.5665\/sleep.4068","article-title":"Electroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjects","volume":"37","author":"Ma","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.brainres.2019.146359_b0395","first-page":"38","article-title":"Sleep disorders in substance abusers: how common are they?","volume":"6","author":"Mahfoud","year":"2009","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.brainres.2019.146359_b0400","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-444-59489-1.00007-0","article-title":"Multiple roles for orexin\/hypocretin in addiction","volume":"198","author":"Mahler","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.brainres.2019.146359_b0405","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nn.3810","article-title":"Motivational activation: a unifying hypothesis of orexin\/hypocretin function","volume":"17","author":"Mahler","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2019.146359_b0410","article-title":"Cognitive dysfunction in individuals with cocaine use disorder: potential moderating factors and pharmacological treatments","author":"Mahoney","year":"2018","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.brainres.2019.146359_b0415","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.euroneuro.2012.05.016","article-title":"The relationship between lifetime stress and addiction severity in cocaine-dependent participants","volume":"23","author":"Mahoney","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2019.146359_b0420","first-page":"383","article-title":"Neuropharmacology neurobiological mechanisms that contribute to stress-related cocaine use","volume":"76","author":"Mantsch","year":"2014","journal-title":"NP"},{"key":"10.1016\/j.brainres.2019.146359_b0425","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/npp.2013.245","article-title":"Error-related brain activity as a biomarker for cocaine relapse","volume":"39","author":"Marhe","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2019.146359_b0430","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.5665\/sleep.3142","article-title":"Measuring sleep: accuracy, sensitivity, and specificity of wrist actigraphy compared to polysomnography","volume":"36","author":"Marino","year":"2013","journal-title":"Sleep"},{"key":"10.1016\/j.brainres.2019.146359_b0435","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/add.12635","article-title":"Fixation time is a sensitive measure of cocaine cue attentional bias","volume":"109","author":"Marks","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.brainres.2019.146359_b0440","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3389\/fneur.2018.00720","article-title":"Drug seeking and relapse: new evidence of a role for orexin and dynorphin co-transmission in the paraventricular nucleus of the thalamus","volume":"9","author":"Matzeu","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.brainres.2019.146359_b0445","first-page":"374","article-title":"Stressful events and other predictors of remission from drug dependence in the United States: longitudinal results from a national survey","volume":"71","author":"McCabe","year":"2016","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.brainres.2019.146359_b0450","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2869.2011.00917.x","article-title":"Comparison of actigraphy with polysomnography and sleep logs in depressed insomniacs","volume":"21","author":"McCall","year":"2012","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.brainres.2019.146359_b0455","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.brainres.2019.146359_b0460","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1080\/10705511.2016.1186549","article-title":"On using Bayesian methods to address small sample problems","volume":"23","author":"McNeish","year":"2016","journal-title":"Struct. Equ. Model. A Multidiscip. J."},{"key":"10.1016\/j.brainres.2019.146359_b0465","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/hup.778","article-title":"Stress reactivity: biological and subjective responses to the cold pressor and Trier Social stressors","volume":"21","author":"McRae","year":"2006","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.brainres.2019.146359_b0470","series-title":"Belsomra (suvorexant): Prescribing Information","author":"Merck","year":"2018"},{"issue":"Pt A","key":"10.1016\/j.brainres.2019.146359_bib731","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2016.10.018","article-title":"Orexin\/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats","volume":"1654","author":"Moorman","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.146359_b0475","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.drugalcdep.2015.12.004","article-title":"Modafinil and sleep architecture in an inpatient-outpatient treatment study of cocaine dependence","volume":"160","author":"Morgan","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainres.2019.146359_b0480","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1100\/tsw.2007.209","article-title":"Cocaine and sleep: early abstinence","volume":"7","author":"Morgan","year":"2007","journal-title":"Sci. World J."},{"key":"10.1016\/j.brainres.2019.146359_b0485","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1176\/appi.ajp.2009.09050613","article-title":"Normalizing effects of modafinil on sleep in chronic cocaine users","volume":"167","author":"Morgan","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2019.146359_b0490","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrn1345","article-title":"Look away: the anti-saccade task and the voluntary control of eye movement","volume":"5","author":"Munoz","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2019.146359_b0495","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/2277-9531.115822","article-title":"The mental health and substance abuse among youths aged 18 to 29: a comparative study","volume":"2","author":"Nasirzadeh","year":"2013","journal-title":"J. Educ. Heal. Promot."},{"key":"10.1016\/j.brainres.2019.146359_b0500","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brat.2017.07.002","article-title":"The NIH science of behavior change program: transforming the science through a focus on mechanisms of change","volume":"101","author":"Nielsen","year":"2018","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.brainres.2019.146359_b0505","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.conb.2013.01.018","article-title":"A neurocognitive approach to understanding the neurobiology of addiction","volume":"23","author":"Noel","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.brainres.2019.146359_b0510","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1176\/appi.ajp.162.8.1423","article-title":"Anticraving medications for relapse prevention: a possible new class of psychoactive medications","volume":"162","author":"O\u2019Brien","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2019.146359_b0515","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nature10709","article-title":"Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour","volume":"481","author":"Pascoli","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2019.146359_b0520","article-title":"Therapeutics development for addiction: orexin-1 receptor antagonists","author":"Perrey","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.146359_b0525","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12035-012-8255-z","article-title":"The hypocretin\/orexin system: implications for drug reward and relapse","volume":"45","author":"Plaza-Zabala","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2019.146359_b0530","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/00952990701199416","article-title":"Treatment outcome predictors for cocaine dependence","volume":"33","author":"Poling","year":"2007","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.brainres.2019.146359_b0535","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/ADM.0000000000000066","article-title":"Cocaine and cognition: a systematic quantitative review","volume":"8","author":"Potvin","year":"2014","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.brainres.2019.146359_b0540","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.addbeh.2018.01.021","article-title":"Cognitive deficits in individuals with methamphetamine use disorder: a meta-analysis","volume":"80","author":"Potvin","year":"2018","journal-title":"Addict. Behav."},{"key":"10.1016\/j.brainres.2019.146359_b0545","unstructured":"R Core Team, 2018. R: A Language and Environment for Statistical Computing."},{"key":"10.1016\/j.brainres.2019.146359_b0550","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S0140525X0800472X","article-title":"A unified framework for addiction: vulnerabilities in the decision process","volume":"31","author":"Redish","year":"2008","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.brainres.2019.146359_b0555","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1109\/RBME.2018.2811735","article-title":"Promises and challenges in the use of consumer-grade devices for sleep monitoring","volume":"11","author":"Roomkham","year":"2018","journal-title":"IEEE Rev. Biomed. Eng."},{"key":"10.1016\/j.brainres.2019.146359_b0560","unstructured":"SAMHSA, 2015. Treating sleep probelms of people in recovery from substance use disorders."},{"key":"10.1016\/j.brainres.2019.146359_b0565","article-title":"The role of the orexin system in stress response","author":"Sargin","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.146359_b0570","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-013-2973-4","article-title":"Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy","volume":"227","author":"Schmechtig","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2019.146359_b0575","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/add.13868","article-title":"PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial","volume":"112","author":"Schmitz","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.brainres.2019.146359_b0580","series-title":"Handbook of Psychopharmacology","article-title":"Pharmacological treatment of psychostimulant disorders","author":"Schmitz","year":"2019"},{"key":"10.1016\/j.brainres.2019.146359_b0585","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s002130100917","article-title":"How does stress increase risk of drug abuse and relapse?","volume":"158","author":"Sinha","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2019.146359_b0590","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1196\/annals.1441.030","article-title":"Chronic stress, drug use, and vulnerability to addiction","volume":"1141","author":"Sinha","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2019.146359_b0595","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-28720-6_150","article-title":"Modeling relapse situations in the human laboratory","author":"Sinha","year":"2011","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.brainres.2019.146359_b0600","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11920-011-0224-0","article-title":"New findings on biological factors predicting addiction relapse vulnerability","volume":"13","author":"Sinha","year":"2011","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.brainres.2019.146359_b0605","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.conb.2013.05.001","article-title":"The clinical neurobiology of drug craving","volume":"23","author":"Sinha","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.brainres.2019.146359_b0610","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/15504263.2016.1146383","article-title":"Cognitive function as a transdiagnostic treatment target in stimulant use disorders","volume":"12","author":"Sofuoglu","year":"2016","journal-title":"J. Dual Diagn."},{"key":"10.1016\/j.brainres.2019.146359_b0615","unstructured":"Stan Development Team, 2018. RStan: the R interface to Stan. R package version 2.18.2."},{"key":"10.1016\/j.brainres.2019.146359_b0620","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.neuropharm.2018.02.010","article-title":"Hypocretin\/orexin deficiency decreases cocaine abuse liability","volume":"133","author":"Steiner","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.146359_b0625","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jsat.2004.03.008","article-title":"Gender differences in cue exposure reactivity and 9-month outcome","volume":"27","author":"Sterling","year":"2004","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.brainres.2019.146359_b0630","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2567","article-title":"Effects of acute buspirone administration on inhibitory control and sexual discounting in cocaine users","volume":"32","author":"Strickland","year":"2017","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.brainres.2019.146359_b0635","article-title":"Orexin\/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: potential for therapy","author":"Summers","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.146359_b0640","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pharep.2017.07.011","article-title":"Drugs which influence serotonin transporter and serotonergic receptors: pharmacological and clinical properties in the treatment of depression","volume":"70","author":"Taciak","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.brainres.2019.146359_b0645","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1521-0391.2011.00121.x","article-title":"Substance use disorders assessed using the Kreek-McHugh-Schluger-Kellogg (KMSK) scale in an urban low-income and predominantly African American sample of primary care patients","volume":"20","author":"Tang","year":"2011","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.brainres.2019.146359_b0650","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12888-015-0409-x","article-title":"Sleeping problems in Chinese illicit drug dependent subjects","volume":"15","author":"Tang","year":"2015","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.brainres.2019.146359_b0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199729","article-title":"Measures of possible allostatic load in comorbid cocaine and alcohol use disorder: Brain white matter integrity, telomere length, and anti-saccade performance","volume":"14","author":"Tannous","year":"2019","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"10.1016\/j.brainres.2019.146359_b0660","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1046\/j.1360-0443.95.8s2.7.x","article-title":"Challenges in the manipulation, assessment and interpretation of craving relevant variables","volume":"95","author":"Tiffany","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.brainres.2019.146359_b0665","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/pr.109.001321","article-title":"Orexin\/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system","volume":"61","author":"Tsujino","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.brainres.2019.146359_b0670","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00045391-199701000-00008","article-title":"The cold pressor test: pharmacological and therapeutic aspects","volume":"4","author":"Velasco","year":"1997","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.brainres.2019.146359_b0675","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/10550887.2015.1116354","article-title":"Attentional bias in adults with cannabis use disorders","volume":"35","author":"Vujanovic","year":"2016","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.brainres.2019.146359_b0680","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/7854_2016_55","article-title":"The role of orexins\/hypocretins in alcohol use and abuse","volume":"33","author":"Walker","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.brainres.2019.146359_b0685","series-title":"Neurobiology of Addictions","article-title":"Behavioral mechanisms in addiction","author":"Wardle","year":"2016"},{"key":"10.1016\/j.brainres.2019.146359_b0690","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1037\/a0028991","article-title":"Acute alcohol effects on attentional bias in heavy and moderate drinkers","volume":"27","author":"Weafer","year":"2013","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.brainres.2019.146359_b0695","doi-asserted-by":"crossref","DOI":"10.1111\/add.13053","article-title":"Using Bayesian analysis for hypothesis testing in addiction science","author":"West","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.brainres.2019.146359_b0700","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4088\/JCP.13m08862","article-title":"Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence","volume":"75","author":"Winhusen","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.brainres.2019.146359_b0705","article-title":"The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task","volume":"0\u20131","author":"Wiskerke","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.146359_b0710","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1037\/0003-066X.59.4.224","article-title":"Relapse prevention for alcohol and drug problems: that was Zen, this is Tao","volume":"59","author":"Witkiewitz","year":"2004","journal-title":"Am. Psychol."},{"key":"10.1016\/j.brainres.2019.146359_b0715","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrn.2016.39","article-title":"Synaptic mechanisms underlying persistent cocaine craving","volume":"17","author":"Wolf","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2019.146359_b0720","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/ntr\/nts268","article-title":"A systematic review of the relationships between craving and smoking cessation","volume":"15","author":"Wray","year":"2013","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.brainres.2019.146359_b0725","doi-asserted-by":"crossref","DOI":"10.1037\/pha0000274","article-title":"Assessing attentional bias and inhibitory control in cannabis use disorder using an eye-tracking paradigm with personalized stimuli","author":"Yoon","year":"2019","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.brainres.2019.146359_b0730","article-title":"The potential role of the orexin reward system in future treatments for opioid drug abuse","author":"Zarrabian","year":"2018","journal-title":"Brain Res."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319304135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319304135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:03:40Z","timestamp":1762103020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899319304135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":147,"alternative-id":["S0006899319304135"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2019.146359","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2019.146359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"146359"}}